Insiders · Profile

Stewart Murray

Interim Chief Medical Officer at X4 Pharmaceuticals. Filing since 10 Aug 2023. CIK 0001723450

Company
Date
Role
Action
Shares
Amount
Of holding
10 Aug 2023
Interim Chief Medical Officer
Sold at will
130,056
$137.86K
47.0%
1 decision on file.